Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2
- 1 November 2007
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 19 (11), 2304-2316
- https://doi.org/10.1016/j.cellsig.2007.07.007
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Homo-oligomerization of ALS2 through Its Unique Carboxyl-terminal Regions Is Essential for the ALS2-associated Rab5 Guanine Nucleotide Exchange Activity and Its Regulatory Function on Endosome TraffickingPublished by Elsevier ,2004
- Agonist-dependent Dissociation of Human Somatostatin Receptor 2 DimersJournal of Biological Chemistry, 2004
- Roles of G‐protein‐coupled receptor dimerizationEMBO Reports, 2004
- Heterodimerization of Somatostatin and Opioid Receptors Cross-modulates Phosphorylation, Internalization, and DesensitizationJournal of Biological Chemistry, 2002
- Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and FunctionAnnual Review of Pharmacology and Toxicology, 2002
- Homo- and Heterodimerization of Somatostatin Receptor SubtypesJournal of Biological Chemistry, 2001
- Oligomerization of G-protein-coupled transmitter receptorsNature Reviews Neuroscience, 2001
- Receptors for Dopamine and Somatostatin: Formation of Hetero-Oligomers with Enhanced Functional ActivityScience, 2000
- Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and HeterodimersJournal of Biological Chemistry, 2000
- G-protein-coupled receptor heterodimerization modulates receptor functionNature, 1999